Five individual applications entered public review

FMCSA published a Federal Register notice on November 16 announcing that five individuals have applied for exemptions related to implantable cardioverter-defibrillators, commonly called ICDs. If FMCSA eventually grants an application, the named person could operate a commercial motor vehicle in interstate commerce under the terms of that individual exemption. Comments on docket FMCSA-2026-0064 are due on or before December 16, 2026.

The current cardiovascular qualification standard remains in force

Under 49 CFR 391.41(b)(4), an interstate CMV driver must have no current clinical diagnosis of specified cardiovascular disease of a type known to be accompanied by syncope, shortness of breath, collapse or congestive heart failure. FMCSA’s medical advisory criteria state that ICDs address an ongoing underlying cardiovascular condition and that both the condition and a device discharge may create a risk of syncope or collapse. The notice therefore describes ICDs as medically disqualifying under the present criteria.

No exemption has been granted by this notice

The publication is a notice of applications and a request for comments, not a final decision. It does not authorize any applicant to drive under an exemption, create a general ICD waiver, revise the medical examiner’s responsibilities or change the qualification of another driver with a similar device or diagnosis. FMCSA must issue a separate Federal Register decision granting or denying the requests.

FMCSA will apply an equivalent-safety test

The agency says it will evaluate each application, the applicant’s safety analysis, public comments, medical advisory criteria, research reports and the individual’s medical information. Federal law requires FMCSA to determine whether an exemption would likely achieve a level of safety equal to or greater than the level achieved without the exemption. If granted, the decision must identify the regulatory provision, effective period and conditions. FMCSA states that medical exemptions are issued for up to two years to align with the maximum medical-certificate period.

Comments are public and should avoid unnecessary personal information

Interested parties may comment through Regulations.gov or the other methods listed in the notice, using docket FMCSA-2026-0064. FMCSA says ordinary comments are posted without editing and may include searchable personal information supplied by the commenter. The public docket is not a place to seek a personal diagnosis or publish unnecessary private health details. Drivers with medical questions should consult qualified medical professionals and the applicable official certification process.

Driver and fleet takeaway

A driver with an ICD or related cardiovascular condition should not treat this notice, a cardiologist’s letter or another person’s application as authority to operate in interstate commerce. Work with the treating clinician and a certified medical examiner, follow FMCSA’s individual exemption process when applicable, and wait for a final written decision before relying on an exemption. Fleets should verify the driver’s current medical certificate, CDL status and any individual exemption document—including its name, effective dates and conditions—before dispatch. Keep required records in the driver qualification file and calendar expiration or reporting deadlines. New chest pain, fainting, shortness of breath, device discharge or other urgent symptoms require immediate medical attention, not a compliance interpretation.

SOURCE PUBLICATION

Federal Motor Carrier Safety Administration — ICD Exemption Applications, Docket FMCSA-2026-0064

This original summary adds CDL-focused context. Visit the named publication for its full reporting and later updates.

Visit source publication →